Abstract
Pituitary failure occurs due to multiple reasons including genetic abnormalities, trauma, infections, empty sella syndrome, Sheehan’s syndrome, etc.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Iron deposition is common in thalassaemia patients with frequent blood transfusions.
References
Mancall, EL, Brock, DG, editors. “Cranial Fossae”. Gray’s clinical anatomy. Philadelphia, PA: Elsevier Health Sciences; 2011. p. 154. ISBN 9781437735802https://en.wikipedia.org/wiki/Middle_cranial_fossa.
Boron WF, Boulpaep EL. Medical physiology. 2nd ed. Philadelphia: Saunders Elsevier; 2009. p. 1016–7.
Musolino NR, Marino Junior R, Bronstein MD. Headache in acromegaly: dramatic improvement with the somatostatin analogue SMS 201–995. Clin J Pain. 1990;6:243–5.
Maccagnan P, Macedo CL, Kayath MJ, Nogueira RG, Abucham J. Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab. 1995;80:2190–7.
Pei L, Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol. 1997;11:433–41.
Brain Tumor Registry of Japan. Neurol Med Chir (Tokyo). 1992;32(7 spec no):381–547.
Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin N Am. 1999;28:81–117, vi.
Melmed S. Acromegaly. In: DeGroot LJ, Jameson JL, Burger H, et al., editors. Endocrinology. 4th ed. Philadelphia: WB Saunders; 2001. p. 300–12.
Arnold AC. Neuro-ophthalmologic evaluation of pituitary disorders. In: Melmed S, editor. The pituitary. Malden: Blackwell; 2002. p. 687–708.
Turner HE, Nagy Z, Gatter KC, et al. Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab. 2000;85:1159–62.
Kucharczyk W, Lenkinski RE, Kucharczyk J, Henkelman RM. The effect of phospholipid vesicles on the NMR relaxation of water: an explanation for the MR appearance of the neurohypophysis? AJNR Am J Neuroradiol. 1990;11:693–700.
Vidal S, Rotondo F, Horvath E, Kovacs K, Scheithauer BW. Immunocytochemical localization of mast cells in lymphocytic hypophysitis. Am J Clin Pathol. 2002;117:478–83.
Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008;359(4):391–403.
Pallan S, Khan A. Primary hyperparathyroidism: update on presentation, diagnosis, and management in primary care. Can Fam Physician. 2011;57(2):184–9.
Malone JP, Srivastava A, Khardori R. Hyperparathyroidism and multiple endocrine neoplasia. Otolaryngol Clin N Am. 2004;37(4):715–36, viii.
Ahmad R, Hammond JM. Primary, secondary, and tertiary hyperparathyroidism. Otolaryngol Clin N Am. 2004;37(4):701–13, vii–viii.
Taniegra ED. Hyperparathyroidism. Am Fam Physician. 2004;69(2):333–9.
Stearns M, Cox J. Parathyroid disease: symptoms, differential diagnosis, and management. In: Arora A, Tolley NS, Tuttle RM, editors. A practical manual of thyroid and parathyroid disease. Chichester: Wiley- Blackwell; 2010. p. 145–63.
Silverberg SJ, Bilezikian JP. The diagnosis and management of asymptomatic primary hyperparathyroidism. Nat Clin Pract Endocrinol Metab. 2006;2(9):494–503.
Michels TC, Kelly KM. Parathyroid disorders. Am Fam Physician. 2013;88(4):249–57.
Suliburk JW, Perrier ND. Primary hyperparathyroidism. Oncologist. 2007;12(6):644–53.
Stack BC, Randolph G. Parathyroid disease: investigations. In: Arora A, Tolley NS, Tuttle RM, editors. A practical manual of thyroid and parathyroid disease. Chichester: Wiley-Blackwell; 2010. p. 164–73.
Marsh DJ, Gimm O. Multiple endocrine neoplasia: types 1 and 2. Adv Otorhinolaryngol. 2011;70:84–90.
Khan AA, Bilezikian JP, Potts Jr JT. Guest Editors for the Third International Workshop on Asymptomatic Primary Hyperparathyroidism. The diagnosis and management of asymptomatic primary hyperparathyroidism revisited. J Clin Endocrinol Metab. 2009;94(2):333–4.
Bilezikian JP, Khan AA, Potts Jr JT. Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94(2):335–9.
Dillon ML, Frazee LA. Cinacalcet for the treatment of primary hyperparathyroidism. Am J Ther. 2011;18(4):313–22.
Khan A, Grey A, Shoback D. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop. J Clin Endocrinol Metab. 2009;94(2):373–81.
Cooper MS, Gittoes NJ. Diagnosis and management of hypocalcaemic [published correction appears in BMJ. 2008;336(7659). http://www.bmj.com/content/336/7659/0.2. Accessed Jun 30, 2015]. BMJ. 2008;336(7656):1298–302.
Fuleihan GE, Silverberg SJ. Diagnosis and differential diagnosis of primary hyperparathyroidism. UpToDate. 11 Feb 2011. http://www.uptodate.com/contents/diagnosis-and-differential-diagnosis-of primaryhyperparathyroidism[subscription required]. Accessed 30 Jun 2015.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer India
About this chapter
Cite this chapter
George, A.J., David, S.S. (2016). Pituitary and Parathyroid Disorders. In: David, S. (eds) Clinical Pathways in Emergency Medicine. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2710-6_41
Download citation
DOI: https://doi.org/10.1007/978-81-322-2710-6_41
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2708-3
Online ISBN: 978-81-322-2710-6
eBook Packages: MedicineMedicine (R0)